Alexander Philipp

LMU Klinikum — Germany

Medicine · Health Sciences

16h-index1.8kcitations70works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(20), RNA Interference and Gene Delivery(12), Advanced biosensing and bioanalysis techniques(10), Cancer Immunotherapy and Biomarkers(9), Genetic factors in colorectal cancer(9)

Publications70 total

Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)
Therapeutic Advances in Medical Oncology·2026Open Access
Adiposity and myosteatosis impact clinical outcomes and shape systemic immunity in immunotherapy-treated HCC patients
Zeitschrift für Gastroenterologie·2026
What can claims data tell us about risk factors and survival of patients with hepatocellular carcinoma? Insights from a German population-based study
Frontiers in Oncology·2025Open Access
1485P Atezolizumab plus bevacizumab before or after transarterial chemoembolization in hepatocellular carcinoma: Interim analysis of the DEMAND (AIO-HEP-0418) randomized phase II clinical trial
Annals of Oncology·2025
1500P SOLARIS: A phase-II open-label Study of pembrOlizumab and Lenvatinib in patients with Advanced stage hepatocellular carcinoma who are Refractory to atezolizumab and bevacizumab/ IO-baSed therapy (IKF t-037 trial)
Annals of Oncology·2025Open Access
Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based study
Therapeutic Advances in Medical Oncology·2025· 2 citedOpen Access
Actual and Perceived Risk of Colorectal Neoplasia in First-Degree Relatives of Patients with Colorectal Cancer
Clinical and Translational Gastroenterology·2025Open Access
Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity
JHEP Reports·2025· 1 citedOpen Access
Sequential or up-front triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma (AIO-MONTBLANC): Safety interim analysis.
Journal of Clinical Oncology·2025· 1 cited
Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis
Journal of Hepatocellular Carcinoma·2025· 1 citedOpen Access
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report
Oncology Research and Treatment·2025· 1 cited
Einfluss von BMI und Körper-Kompositionsparametern auf die Effektivität von Immuncheckpoint-Inhibitoren im HCC
Zeitschrift für Gastroenterologie·2025
IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC)—The IKF-IMMULAB trial.
Journal of Clinical Oncology·2025
Adiposity and myosteatosis are prognostic biomarkers in advanced HCC patients receiving immunotherapy
Zeitschrift für Gastroenterologie·2025
Use of Immune Checkpoint Inhibitors Prior to and After Liver Transplantation
2025
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
Hepatology·2024· 22 cited
OS-112-YI Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapybased systemic therapy
Journal of Hepatology·2024· 4 cited
186P Patients’ characteristics, outcomes, and costs of liver transplantation in patients with hepatocellular carcinoma in Germany
Annals of Oncology·2024Open Access
195P Risk factors in patients with hepatocellular carcinoma: A German claims data analysis
Annals of Oncology·2024· 1 citedOpen Access
Diagnostik und Therapie von hepatobiliären Tumoren
InFo Hämatologie + Onkologie·2024
page 1 of 4Next →

Frequent Co-authors

Julia Mayerle(20), Najib Ben Khaled(18), Enrico N. De Toni(17), Florian P. Reiter(14), Andreas Geier(13), Ernst Wagner(10), Max Seidensticker(10), Andreas Herbst(8), Christian M. Lange(8), Ursula Ehmer(8), Karin Berger(8), Osman Öcal(7), Daniel Rössler(7), Jens Ricke(7), P Stieber(6), Frank T. Kolligs(6), Stefan Munker(6), Martin Meyer(5), Dorothea Nagel(5), Daniel Roessler(5)